Corcept Therapeutics Inc. buy Canaccord Genuity Group Inc.
Start price
28.05.26
/
50%
€59.40
Target price
28.05.27
€116.49
Performance (%)
71.89%
Price
18.08.26
€102.10
Summary
This prediction is currently active. With a performance of 71.89% the BUY prediction by Canaccord_Genuity_Gr is a big success. This prediction currently runs until 28.05.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Corcept Therapeutics Inc. | 5.366% | 5.366% |
| iShares Core DAX® | -0,87 % | 5,32 % |
| iShares Nasdaq 100 | -0,38 % | 1,98 % |
| iShares Nikkei 225® | -1,68 % | 1,95 % |
| iShares S&P 500 | -0,65 % | 2,07 % |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Corcept Therapeutics Inc. diskutieren
Corcept Therapeutics (CORT) had its price target raised by Canaccord Genuity Group Inc. from $110.00 to $135.00. They now have a "buy" rating on the stock.
Ratings data for CORT provided by MarketBeat
Stopped prediction by Canaccord_Genuity_Gr for Corcept Therapeutics Inc.
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€33.55
26.03.26
26.03.26
€95.16
26.03.27
26.03.27
204.32%
18.08.26
18.08.26
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€19.83
08.03.23
08.03.23
€30.31
08.03.24
08.03.24
7.94%
09.03.24
09.03.24